| Sample | Title | Value | Rank |
|---|
| GSM303966 | SLE-7 #4 @12wks, asymptomatic (-2077090517) | 10.0364 | 25 |
| GSM303972 | SLE-7 #3 @12wks, asymptomatic (-2077090523) | 8.35525 | 21 |
| GSM303986 | SLE-7 #2 @12wks, asymptomatic (-2077090529) | 13.061 | 28 |
| GSM303991 | SLE-7 #1 @12wks, asymptomatic (-2077090535) | 7.79309 | 19 |
| GSM303961 | SLE-7 #1 @36wks, asymptomatic on treatment with sirolimus (-2101366109) | 6.07817 | 11 |
| GSM303979 | SLE-7 #3 @36wks, asymptomatic on treatment with sirolimus (-2101365196) | 23.7861 | 32 |
| GSM303985 | SLE-7 #2 @36wks, asymptomatic on treatment with sirolimus (-2101365652) | 15.9239 | 28 |
| GSM303971 | SLE-7 #2 @36wks, diseased/symptomatic (-2101366115) | 12.0054 | 24 |
| GSM303973 | SLE-7 #1 @36wks, diseased/symptomatic (-2101366147) | 16.2043 | 27 |
| GSM303980 | SLE-7 #3 @36wks, diseased/symptomatic (-2102085829) | 12.7945 | 21 |
| GSM303962 | SLE-7 #3 @42wks, asymptomatic on treatment with sirolimus (-2101365164) | 19.2431 | 29 |
| GSM303978 | SLE-7 #2 @42wks, asymptomatic on treatment with sirolimus (-2102085846) | 6.53056 | 12 |
| GSM303982 | SLE-7 #1 @42wks, asymptomatic on treatment with sirolimus (-2101365170) | 3.95044 | 5 |
| GSM303965 | SLE-7 #2 @42wks, diseased/symptomatic (-2102085823) | 11.2847 | 19 |
| GSM303968 | SLE-7 #1 @42wks, diseased/symptomatic (-2101365185) | 6.21343 | 12 |
| GSM303981 | SLE-7 #3 @42wks, diseased/symptomatic (-2101365176) | 4.74273 | 10 |